![](/img/cover-not-exists.png)
PMS43 COST-UTILITY AND MULTINOMIAL EXPECTED VALUE OF PERFECT INFORMATION OF SEQUENCED TREATMENT WITH BIOLOGICS IN MODERATE-TO-SEVERE RHEUMATOID ARTHRITIS: ANALYSIS BASED ON CLINICALLY MEANINGFUL RESPONSES
EJ Soini, T Hallinen, MJ Kauppi, V Vihervaara, K PuolakkaVolume:
13
Year:
2010
Language:
english
DOI:
10.1016/s1098-3015(11)72196-9
File:
PDF, 77 KB
english, 2010